Foresight Acquisition Files Proxy on $2.3B P3 Deal

Foresight Acquisition

Foresight Acquisition filed a proxy statement today outlining details of its proposed merger with P3 Health Partners. The deal values the combined company at $2.3 billion. A shareholder vote is set for Nov. 18.

Announced in May, proceeds would consist of up to $316 million of cash held in Foresight’s trust, assuming no redemptions, and an additional $200 million PIPE, including participation from funds and accounts managed by Fidelity Management & Research Company and Janus Henderson Investors.

P3 is a physician-led population health management company that supports providers, physicians, and practices in value-based systems of care and wellness. P3 is a portfolio company of Chicago Pacific Founders who provided P3’s initial and growth capital.

Pending regulatory and shareholder approvals, upon closing P3 Health Partners would list on the Nasdaq. Read more.

Total
0
Shares
Related Posts
Read More

Melar Acquisition I Registers for $150M IPO

Melar I said it expects to focus on a target in retail finance, specialty finance, or financial technology that are positioned to benefit directly from the growth of economic stability and financial technologies in their target markets, a sector which the SPAC refers to as “emerging finance.”